Designing of heterocyclic compounds as promising VEGFR2 tyrosine kinase inhibitors: An Insilico analysis. (2021). International Journal of Pharmaceutical Sciences and Drug Research, 13(6), 685-698. https://doi.org/10.25004/IJPSDR.2021.130612